scPharmaceuticals Inc (SCPH)
4.66
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
4.65
-0.01
(-0.21%)
Pre-Market: 20:00
scPharmaceuticals Cash from Investing (TTM): 19.96M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 19.96M |
September 30, 2023 | -49.49M |
June 30, 2023 | -15.78M |
March 31, 2023 | -26.07M |
December 31, 2022 | -45.86M |
September 30, 2022 | 1.634M |
June 30, 2022 | 0.371M |
March 31, 2022 | 6.635M |
Date | Value |
---|---|
December 31, 2021 | 32.13M |
September 30, 2021 | 64.33M |
June 30, 2021 | 25.12M |
March 31, 2021 | -20.76M |
December 31, 2020 | -33.46M |
September 30, 2020 | -70.16M |
June 30, 2020 | -40.47M |
March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-70.16M
Minimum
Sep 2020
64.33M
Maximum
Sep 2021
-9.491M
Average
-7.890M
Median
Cash from Investing (TTM) Benchmarks
Anika Therapeutics Inc | -5.427M |
Spero Therapeutics Inc | 0.00 |
electroCore Inc | -0.206M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |